Primary Site >> Biliary tract Cancer
Gene >> PROM1
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. PMID: 18542072 |
Ref: Characterization of CD133+ parenchymal cells in the liver: histology and culture. PMID: 19842219 |
Ref: CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. PMID: 20948317 |
Ref: Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi. PMID: 20437099 Ref: CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells. PMID: 20568110 Ref: Strong expression of CD133 is associated with increased cholangiocarcinoma progression. PMID: 21448425 Ref: Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line GBC-SD. PMID: 21462380 Ref: CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity. PMID: 21734809 Ref: Arsenic oxide targets stem cell marker CD133/prominin-1 in gallbladder carcinoma. PMID: 21788103 Ref: CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. PMID: 21798073 Ref: Development of intrahepatic cholangiocarcinoma after a 14-year follow-up of a patient with primary sclerosing cholangitis and ulcerative colitis. PMID: 22118304 Ref: Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma. PMID: 22146626 |
Ref: Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater. PMID: 22130902 Ref: Distinctive expression of CD133 between intraductal papillary neoplasms of the bile duct and bile duct adenocarcinomas. PMID: 22221899 Ref: Association of stem cell marker expression pattern and survival in human biliary tract cancer. PMID: 22614781 Ref: Recent advances in cancer stem cell research for cholangiocarcinoma. PMID: 22907641 |
Ref: Characterization of two novel cell lines with distinct heterogeneity derived from a single human bile duct carcinoma. PMID: 23382894 Ref: Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. PMID: 23388123 Ref: Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis. PMID: 23917144 Ref: Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers. PMID: 23955451 Ref: [A case of initially unresectable gallbladder cancer with surgical resection after chemotherapy with gemcitabine]. PMID: 24393908 |
Ref: Establishment of a novel cell line from intraductal papillary neoplasm of the bile duct. PMID: 24778022 Ref: Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome. PMID: 24804938 |
Ref: Profiles of cancer stem cell subpopulations in cholangiocarcinomas. PMID: 25892683 Ref: Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3'-methyl-4 dimethylaminoazobenzene in rats. PMID: 26028817 |
Ref: Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival. PMID: 26318430 Ref: Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient. PMID: 26486326 Ref: Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi. PMID: 26586401 Ref: Epithelial Transforming Growth Factor-beta Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma. PMID: 26627606 Ref: CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation. PMID: 26910892 |
Ref: BRAF V600E mutation in biliary proliferations associated with alpha1 -antitrypsin deficiency. PMID: 27627051 Ref: Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. PMID: 28930164 Ref: Isolation and identification of tumor-initiating cell properties in human gallbladder cancer cell lines using the marker cluster of differentiation 133. PMID: 29344142 |
Ref: Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. PMID: 29169115 Ref: CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma. PMID: 29510695 Ref: Classification of gallbladder cancer by assessment of CD8(+) TIL and PD-L1 expression. PMID: 30055582 |